-27%

Sevlaren 400mg Tablet 10’S

$11.00

Sevlaren 400mg Tablet 10’S

Sevlaren 400mg Tablet 10’S

$11.00

Add to cart
Buy Now

INTRODUCTION:

SEVLAREN 400MG contains Sevelamer carbonate which belongs to a class of medicines called Phosphate binders. It binds phosphate from food in the digestive tract and reduces serum phosphorus levels in the blood. It is used to control hyperphosphataemia in dialysis, for patients undergoing haemodialysis or peritoneal dialysis and with chronic kidney disease who are not on dialysis and have a serum phosphorus level equal to or above 1.78 mmol/l. It works by preventing hyperphosphatemia by binding to dietary phosphate in the gut and thus preventing its absorption and decreases serum phosphate levels.

High levels of serum phosphorus can lead to hard deposits in your body called calcification. These deposits can stiffen your blood vessels and make it harder for blood to be pumped around the body. It can also lead to itchy skin, red eyes, bone pain and fractures.

Take this medicine according to the dose and frequency as advised by your doctor. Swallow it as a whole. Do not chew, crush or break the medicine. This medicine has no or negligible influence on the ability to driving or using machines. It is not recommended for pregnant women and breastfeeding mothers. The most common side effect is constipation. It is not recommended for use in children below 6 years of age.

USES OF SEVLAREN 400MG:

Used to control hyperphosphataemia (high phosphate levels in blood)

HOW SEVLAREN 400MG WORKS:

SEVLAREN 400MG works by preventing hyperphosphatemia by binding to dietary phosphate in the gut and thus preventing its absorption and decreases serum phosphate levels.

DIRECTIONS FOR USE:

Take SEVLAREN 400MG according to the dose and frequency as advised by your doctor. Swallow it as a whole. Do not chew, crush or break the medicine. It may be taken with food.

SIDE EFFECTS OF SEVLAREN 400MG:

COMMON

• Constipation

RARE

• Allergic reactions such as swelling of the face, lips, tongue and throat causes difficulty breathing or swallowing

HOW TO MANAGE SIDE EFFECTS:

Constipation:

Eat fruits, vegetables whole grains and high rich fiber foods.

WARNING AND PRECAUTIONS:

PREGNANCY

SEVLAREN 400MG should be used with caution in pregnant women. Consult your doctor before taking this medicine.

BREASTFEEDING

SEVLAREN 400MG should be used with caution during breastfeeding. Consult your doctor before taking this medicine.

DRIVING AND USING MACHINES

This medicine has no or negligible influence on the ability to driving or using machines.

ALLERGY

Do not take if you are allergic (hypersensitive) to Sevelamer carbonate.

OTHERS

Inform your doctor if you have,

Low levels of phosphate in your blood
Bowel obstruction
Swallowing problems
Problems with motility stomach and bowel
Being sick frequently
Inflammation of the bowel
Major surgery

INTERACTIONS:

Tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or the following,

Ciprofloxacin
Medicines used to treat heart problems and epilepsy
Ciclosporin, mycophenolate mofetil and tacrolimus (medicines used to suppress the immune system)
Levothyroxine (used to treat thyroid)
Omeprazole, pantoprazole or lansoprazole

SYNOPSIS:

Drug : Sevelamer carbonate
Pharmacological Category : Phosphate binder
Therapeutic Indication : Control of serum phosphorous
Dosage Forms : Tablet, Capsule, Powder, Sachet

MORE INFORMATION:

Store below 20-25°C and keep out of reach of children.

FAQ’s ABOUT SEVLAREN 400MG:

Q: For how long do I need to consume SEVLAREN 400MG?
A: Take as recommended by your doctor. If you stop suddenly it may result in an increase in your phosphate levels.

Q: Can SEVLAREN 400MG be given in children?
A: This medicine is not recommended for use in children below 6 years of age.

 

Category from : Sevlaren 400mg Tablet 10’S

Brand

La Renon Healthcare Pvt Ltd

Reviews

There are no reviews yet.

Be the first to review “Sevlaren 400mg Tablet 10’S”

Your email address will not be published. Required fields are marked *

Top